Literature DB >> 11776348

Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital.

C R MacIntyre1, M Empson, C Boardman, D Sindhusake, J Lokan, G V Brown.   

Abstract

OBJECTIVE: To determine risk factors for colonization with vancomycin-resistant enterococci (VRE) in a hospital outbreak.
DESIGN: Outbreak investigation and case-control study.
SETTING: A referral teaching hospital in Melbourne, Australia. PARTICIPANTS: Cases were inpatients colonized (with or without clinical disease) with VRE between July 26 and November 28, 1998; controls were hospitalized patients without VRE.
METHODS: Five cases of VRE were identified between July 26 and November 8, 1998, by growth of VRE from various sites. Active case finding by cultures of rectal swabs from patients surveyed in wards was commenced on July 26, after the first isolate of VRE.
RESULTS: There were 19 cases and 66 controls. All the VRE identified were vanB, and all were Enterococcus faecium. One molecular type predominated (18/19 cases). In a logistic-regression model, being on the same ward as a VRE case was the highest risk factor (odds ratio [OR], 82; 95% confidence interval [CI95], 5.7-1,176; P=.001). Having more than five antibiotics (OR, 11.9; CI95 1.1-129.6; P<.05), use of metronidazole (OR, 10.9; CI95, 1.7-69.8; P=.01), and being a medical patient (OR, 8.1; CI95, 1.4-47.6; P<.05) also were significant. Intensive care unit admission was associated with decreased risk (OR, 0.1; CI95, 0.01-0.8; P<.05).
CONCLUSION: Our findings are consistent with an acute hospital outbreak. Monitoring and control of antibiotic use, particularly metronidazole, may reduce VRE in our hospital. Ongoing surveillance and staff education also are necessary.

Entities:  

Mesh:

Year:  2001        PMID: 11776348     DOI: 10.1086/501833

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

1.  Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.

Authors:  E M Mascini; K P Jalink; T E M Kamp-Hopmans; H E M Blok; J Verhoef; M J M Bonten; A Troelstra
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.

Authors:  M Papadimitriou-Olivgeris; E Drougka; F Fligou; F Kolonitsiou; A Liakopoulos; V Dodou; E D Anastassiou; E Petinaki; M Marangos; K S Filos; I Spiliopoulou
Journal:  Infection       Date:  2014-08-21       Impact factor: 3.553

3.  Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.

Authors:  Young-Bem Se; Hyoung-Joon Chun; Hyeong-Joong Yi; Dong-Won Kim; Yong Ko; Suck-Jun Oh
Journal:  J Korean Neurosurg Soc       Date:  2009-08-31

4.  Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department.

Authors:  Aude Servais; Lucile Mercadal; Florence Brossier; Marcia Venditto; Belkacem Issad; Corinne Isnard-Bagnis; Gilbert Deray; Jérôme Robert
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

5.  Factors associated with acquisition of glycopeptide-resistant enterococci during a single-strain outbreak.

Authors:  S Deboscker; P Schneider; F Séverac; C Ménard; J Gaudart; T Lavigne; N Meyer
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  Vancomycin-resistant Enterococcus faecium COLONIZATION and Clostridium difficile infection in a HEMATOLOGIC patient.

Authors:  Ivana Goić-Barišić; Marina Radić; Anita Novak; Žana Rubić; Nataša Boban; Boris Lukšić; Marija Tonkić
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

7.  Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study.

Authors:  Surendra Karki; Leanne Houston; Gillian Land; Pauline Bass; Rosaleen Kehoe; Sue Borrell; Kerrie Watson; Denis Spelman; Jacqueline Kennon; Glenys Harrington; Allen C Cheng
Journal:  Antimicrob Resist Infect Control       Date:  2012-10-08       Impact factor: 4.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.